Results 111 to 120 of about 237,784 (285)
Sexually transmitted disease in gynaecological out-patients with vaginal discharge. [PDF]
Anne Driscoll +3 more
openalex +1 more source
Clinical parameters as predictors of bacterial isolation in the uterine content of dogs suspected of pyometra [PDF]
In this study, female canines referred with clinical signs consistent with pyometra were prospectively evaluated. Signalment, clinical signs, laboratory findings and surgical findings were compared between dogs with and without bacterial isolation based ...
Boyen, Filip +5 more
core +1 more source
As funding mechanisms like the Global Fund for HIV/AIDS, Tuberculosis and Malaria increasingly make funding decisions on the basis of burden of disease estimates and financial need calculations, the importance of reliable and comparable estimating ...
Bertozzi, Stefano +4 more
core +1 more source
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff +6 more
wiley +1 more source
Editorial: Vaginal microecological disorder and gynecological diseases
Tingtao Chen +4 more
doaj +1 more source
Abstract The intestinal microbiome plays a pivotal role in maintaining host health through its involvement in gastrointestinal, immune, and central nervous system (CNS) functions. Recent evidence underscores the bidirectional communication between the microbiota, the gut, and the brain and the impact of this axis on neurological diseases, including ...
Teresa Ravizza +4 more
wiley +1 more source
Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study [PDF]
Background: Ukraine was the epicentre of the HIV epidemic in Eastern Europe, which has the most rapidly accelerating HIV epidemic world-wide today; national HIV prevalence is currently estimated at 1.6%.
Malyuta, R +4 more
core
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
The "3 by 5" goal to have 3 million people in low and middle income countries on antiretroviral therapy (ART) by the end of 2005 is ambitious. Estimates of the necessary resources are needed to facilitate resource mobilisation and rapid channelling of ...
Adam, Taghreed +7 more
core +1 more source

